NM_000203.5:c.1205G>A

Variant summary

Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM3PP4

This summary comes from the ClinGen Evidence Repository: The NM_000203.5:c.1205G>A (p.Trp402Ter) variant in IDUA is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 9 out of a total of 14 exons, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism. Complete loss of IDUA activity was confirmed when the variant was transiently expressed in COS-7 cells (PMID:11735025) (PVS1). This is the most common variant to be identified in patients with mucopolysaccharidosis type 1 (MPS1) in the United States (45% of alleles), Mexico (29%), Colombia (50%), Brazil (29%), the United Kingdom (45%), the Netherlands (42%), Germany (50%), the Czech Republic and Slovakia (33%), Spain (62%) and Australia (34%) (reviewed in PMID:29393969). At least 38 homozygotes (PMID:1301196, 28752568) (max PM3 points = 2 x 0.5 = 1 point for homozygotes), and at least 73 individuals who are compound heterozygous for the variant and a second variant in IDUA, including another well-known pathogenic variant, p.Gln70Ter, have been reported (PMID:1301941, 11735025, 28752568, 30809705). The allelic evidence from these compound heterozygous patients will be used to support the classification of the other variant and is not included here to avoid circular logic (PM3 based on evidence from homozygotes). Patients are reported with detailed clinical features of MPS I or elevated urine GAGs in addition to documentation of laboratory values showing deficient IDUA activity (PMID:1301941, 11735025, 30809705) (PP4). A knock in mouse, homozygous for a variant analogous to p.Trp402Ter (mouse Idua Trp392Ter) was reported to have a phenotype that closely correlates with features in humans patients with MPS1 (PMID:19751987). The highest population minor allele frequency in gnomAD v4.1.0 is 0.001555 (1749/1124730 alleles) in the European non-Finnish population, which is higher than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.00025) and lower than the threshold for BS1 (>0.0025). Therefore, no population codes are met. Additional data is available in the literature but the classification of pathogenic has already been reached. There is a ClinVar entry for this variant (Variation ID: 11908). In summary, this variant is the most frequently reported variant in individuals with MPS1 and meets the criteria to be classified as pathogenic for this disorder. IDUA-specific ACMG/AMP criteria met, as specified by the ClinGen Lysosomal Diseases VCEP (Specifications Version 1.0.0): PVS1, PM3, PP4.(Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on January 3, 2025) LINK:https://erepo.genome.network/evrepo/ui/classification/CA220498/MONDO:0001586/091

Frequency

Genomes: 𝑓 0.00086 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0013 ( 0 hom. )

Consequence

IDUA
NM_000203.5 stop_gained

Scores

4
1
1

Clinical Significance

Pathogenic reviewed by expert panel P:31O:2

Conservation

PhyloP100: 0.133

Publications

181 publications found
Variant links:
Genes affected
IDUA (HGNC:5391): (alpha-L-iduronidase) This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]
IDUA Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
  • Scheie syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • Hurler syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • Hurler-Scheie syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 11 ACMG points.

PVS1
For more information check the summary or visit ClinGen Evidence Repository.
PM3
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000203.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IDUA
NM_000203.5
MANE Select
c.1205G>Ap.Trp402*
stop_gained
Exon 9 of 14NP_000194.2P35475-1
IDUA
NM_001363576.1
c.809G>Ap.Trp270*
stop_gained
Exon 8 of 13NP_001350505.1
IDUA
NR_110313.1
n.1293G>A
non_coding_transcript_exon
Exon 9 of 14

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IDUA
ENST00000514224.2
TSL:2 MANE Select
c.1205G>Ap.Trp402*
stop_gained
Exon 9 of 14ENSP00000425081.2P35475-1
IDUA
ENST00000247933.9
TSL:1
c.1205G>Ap.Trp402*
stop_gained
Exon 9 of 14ENSP00000247933.4P35475-1
IDUA
ENST00000962389.1
c.1280G>Ap.Trp427*
stop_gained
Exon 10 of 15ENSP00000632448.1

Frequencies

GnomAD3 genomes
AF:
0.000860
AC:
130
AN:
151238
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000317
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000287
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00162
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.000585
AC:
53
AN:
90548
AF XY:
0.000489
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000430
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000188
Gnomad NFE exome
AF:
0.00123
Gnomad OTH exome
AF:
0.00111
GnomAD4 exome
AF:
0.00131
AC:
1750
AN:
1334448
Hom.:
0
Cov.:
34
AF XY:
0.00130
AC XY:
852
AN XY:
657900
show subpopulations
African (AFR)
AF:
0.000111
AC:
3
AN:
26968
American (AMR)
AF:
0.000495
AC:
15
AN:
30280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30054
South Asian (SAS)
AF:
0.00
AC:
0
AN:
73662
European-Finnish (FIN)
AF:
0.000328
AC:
11
AN:
33500
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3936
European-Non Finnish (NFE)
AF:
0.00155
AC:
1639
AN:
1056886
Other (OTH)
AF:
0.00148
AC:
82
AN:
55508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
72
144
216
288
360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000859
AC:
130
AN:
151342
Hom.:
0
Cov.:
33
AF XY:
0.000744
AC XY:
55
AN XY:
73930
show subpopulations
African (AFR)
AF:
0.000316
AC:
13
AN:
41138
American (AMR)
AF:
0.000197
AC:
3
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5090
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4802
European-Finnish (FIN)
AF:
0.000287
AC:
3
AN:
10468
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.00162
AC:
110
AN:
67844
Other (OTH)
AF:
0.000475
AC:
1
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00143
Hom.:
1
Bravo
AF:
0.000827
ESP6500AA
AF:
0.000441
AC:
1
ESP6500EA
AF:
0.000453
AC:
2
ExAC
AF:
0.0000565
AC:
1

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
8
-
-
Mucopolysaccharidosis type 1 (9)
8
-
-
not provided (8)
5
-
-
Hurler syndrome (5)
4
-
-
Mucopolysaccharidosis, MPS-I-S;C0086431:Mucopolysaccharidosis, MPS-I-H/S;C0086795:Hurler syndrome (4)
2
-
-
Mucopolysaccharidosis, MPS-I-H/S (2)
2
-
-
See cases (2)
1
-
-
IDUA-related disorder (1)
1
-
-
Inborn genetic diseases (1)
-
-
-
Mucopolysaccharidosis type 1;C0086795:Hurler syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.32
D
BayesDel_noAF
Pathogenic
0.51
CADD
Pathogenic
46
DANN
Uncertain
0.99
Eigen
Pathogenic
0.87
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Benign
0.70
D
PhyloP100
0.13
Vest4
0.60
GERP RS
4.9
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121965019; hg19: chr4-996535; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.